Skip to main content
Retour
Watch Compare

Akebia Therapeutics, Inc.

Qualité des données : 100%
AKBA
Nasdaq Manufacturing Chemicals
1,42 €
▼ 0,02 € (-1,05%)
Cap. Boursière: 379,05 M
Prix
1,42 €
Cap. Boursière
379,05 M
Fourchette du Jour
1,41 € — 1,45 €
Fourchette 52 Semaines
1,14 € — 4,08 €
Volume
782 462
Ouverture 1,42 €
Moyenne 50J / 200J
1,36 €
4,26% above
Moyenne 50J / 200J
2,32 €
39,02% below

Quick Summary

Points Clés

Revenue grew 2,55% annually over 5 years — modest growth
Generating 67,70 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 44,91%
Capital efficient — spends only 0,12% of revenue on capex

Croissance

Revenue Growth (5Y)
2,55%
En dessous de la moyenne du secteur (9,35%)
Revenue (1Y)47,46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-15,10%
Au-dessus de la moyenne du secteur (-51,02%)
ROIC8,11%
Net Margin-2,26%
Op. Margin9,95%

Sécurité

Debt / Equity
1,15
Au-dessus de la moyenne du secteur (0,33)
Current Ratio1,94
Interest CoverageN/A

Valorisation

PE (TTM)
-70,92
En dessous de la moyenne du secteur (-1,98)
P/B Ratio9,11
EV/EBITDA11,07
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -70,9 -2,0
P/B 9,1 5,1
ROE % -15,1 -51,0
Net Margin % -2,3 -150,2
Rev Growth 5Y % 2,6 9,3
D/E 1,2 0,3

ETFs Holding This Stock

FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0,27% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,12% weight
LABU logo LABU Direxion Daily S&P Biotech Bull 3X ETF
0,07% weight
FAD logo FAD First Trust Multi Cap Growth AlphaDEX Fund
0,04% weight
ISCB logo ISCB iShares Morningstar Small-Cap ETF
0,02% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 47,46% Revenue Growth (3Y) 10,16%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 2,55% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 236,20 M Net Income (TTM) -5,35 M
ROE -15,10% ROA -1,51%
Gross Margin N/A Operating Margin 9,95%
Net Margin -2,26% Free Cash Flow (TTM) 67,70 M
ROIC 8,11% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,15 Current Ratio 1,94
Interest Coverage N/A Asset Turnover 0,67
Working Capital 124,96 M Tangible Book Value -17,45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -70,92 Forward P/E N/A
P/B Ratio 9,11 P/S Ratio 1,60
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 11,07 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 17,86%
Market Cap 379,05 M Enterprise Value 260,25 M
Per Share
EPS (Diluted TTM) -0,02 Revenue / Share 0,88
FCF / Share 0,25 OCF / Share 0,25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,12% FCF Conversion -1266,62%
SBC-Adj. FCF 57,97 M Growth Momentum 44,91

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 236,20 M 160,18 M 194,62 M 292,60 M 213,58 M
Net Income -5,35 M -69,41 M -51,93 M -92,56 M -282,84 M
EPS (Diluted) -0,02 -0,33 -0,28 -0,51 -1,70
Gross Profit — — — — —
Operating Income 23,50 M -50,47 M -46,26 M -79,12 M -265,32 M
EBITDA — — — — —
R&D Expenses 62,36 M 37,65 M 63,08 M 129,11 M 147,85 M
SG&A Expenses 107,48 M 106,55 M 100,23 M 138,70 M 174,16 M
D&A — — — 1,65 M 1,93 M
Interest Expense — — — — —
Income Tax 1,62 M — — 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 376,57 M 220,67 M 241,70 M 351,83 M 525,55 M
Total Liabilities 343,96 M 269,86 M 272,29 M 342,49 M 449,09 M
Shareholders' Equity 32,61 M -49,19 M -30,58 M 9,34 M 76,46 M
Total Debt 48,25 M 38,69 M 34,68 M 66,08 M 97,54 M
Cash & Equivalents 184,84 M 51,87 M 42,93 M 90,47 M 149,80 M
Current Assets 252,96 M 113,83 M 118,15 M 184,95 M 272,01 M
Current Liabilities 162,94 M 80,91 M 99,87 M 124,76 M 256,49 M